Breast cancer is the most researched disease globally, yet there are still significant gaps in equity and access to care and treatments.
Gen Li, PhD,MBA
Advertisement
Gen Li, PhD, MBA, is the president and founder of Phesi, a clinical data company utilizing AI-driven solutions to optimize clinical trial data for sponsors and providers to improve patient care and treatments.
Articles by Gen Li, PhD,MBA
The founder and President of Phesi addresses the need for streamlining clinical trial data as GLP-1 RA therapies are being used to treat multiple diseases.
Digital patient profiles and expansive real-world data are reshaping oncology clinical trials, explained Gen Li, PhD, MBA, president and founder of Phesi.
Advertisement
Latest Updated Articles
The Emerging Landscape of GLP-1 RA Therapies Across ConditionsPublished: October 14th 2025 | Updated:
Real-World Data, Digital Patient Profiles Are Revolutionizing Trial Design, Patient Recruitment: Gen Li, PhD, MBAPublished: August 4th 2025 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Sibeprenlimab for Immunoglobulin A Nephropathy
2
Patients Face New Care Complexities as DTC Options Expand
3
Ocrelizumab Leads to Lower Hospitalization Rates Compared to Rituximab in MS
4
Expiring ACA Subsidies and CMS Payment Models Raise Costs for Consumers and Employers
5
